247 HYPOALBUMINEMIA IS A SURROGATE BIOMARKER OF POOR PROGNOSIS IN MYELODYSPLASTIC SYNDROME EVEN WHEN ADJUSTED WITH COMORBIDITIES. Issue 1 (April 2015) - Sevindik, O.; Guc, Z.; Kahraman, S.; Medeni, S.; Katgi, A.; Acar, C.; Alacacioglu, I.; Piskin, O.; Ozsan, H.; Demirkan, F.; Undar, B.; Ozcan, M.